abstract |
The present disclosure encompasses bioprosthetic heart valves with polyphosphazene polymers, such as poly [bis (trifluoroethoxy) phosphazene], that exhibit improved antithrombogenic, biocompatible, and blood compatible properties. . A method of making a bioprosthetic heart valve having a polyphosphazene polymer is also described. [Selection] Figure 5 |